#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypocalcaemia Pemphigus Lupus nephritis Marginal zone lymphoma Chronic inflammatory demyelinating polyradiculoneuropathy Hereditary hypophosphataemic rickets Superficial vein thrombosis Thalassaemia alpha Pseudomyxoma peritonei Renal cancer metastatic Gastrointestinal disorder Partial lipodystrophy Amyotrophic lateral sclerosis Adenovirus infection Fibrodysplasia ossificans progressiva More trials…

    Learn about Rare Diseases

    Medulloblastoma recurrent – Basic Information Pulmonary sarcoidosis – Treatment Isodicentric chromosome 15 syndrome – Treatment Mantle cell lymphoma – Trials in Disease Idiopathic inflammatory myopathy – Life with Disease Antithrombin III deficiency Urea cycle disorder – Life with Disease Mantle cell lymphoma – Treatment Waldenstrom’s macroglobulinaemia – Treatment Uterine leiomyosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Amsacrine Inclisiran Sodium Lovotibeglogene Autotemcel Bromhexine Hydrochloride Onasemnogene Abeparvovec Follitropin Delta Mps-213 Teplizumab SAR445399 HYDROGEN PEROXIDE [Al[18F]F]Fapi-74 Etoposide Phosphate Sodium Chloride Solution 0.9% Serpina1(Human)-Aav8-1 Propofol Dnth103 Empagliflozin Clemastine Fumarate TRIMIPRAMINE MALEATE Gefurulimab More therapies…

    Learn about Your Condition

    Hypochromic anaemia Lysosomal storage disorder Noninfective chorioretinitis Hypotension Thyroid mass Friedreich's ataxia Apathy Encephalitis Japanese B Biliary adenoma Paget's disease of the vulva Cerebral amyloid angiopathy Hyperadrenocorticism Tuberculosis Infertility Fibrosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A study to evaluate the efficacy and safety of zenagamtide in people with obesity

    Recruiting

    3 1
    Belgium Bulgaria Denmark France Germany Italy +2

  • Study to evaluate the efficacy and safety of personalized tissue engineered veins in patients with severe chronic venous insufficiency

    Recruiting

    4 1 1
    Investigated Drugs:
    • ALLOGENEIC VEIN TISSUE SEGMENT, DECELLULARISED, WITH A FUNCTIONAL VALVE PERFUSED WITH AUTOLOGOUS PERIPHERAL BLOOD
    Spain

  • A study of sacituzumab tirumotecan and bevacizumab in patients with newly diagnosed advanced ovarian cancer following first-line platinum-based chemotherapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Bevacizumab
    • Sacituzumab Tirumotecan
    Austria Belgium Czechia Denmark Finland France +9

  • A study of mirikizumab levels in breast milk of breastfeeding women with ulcerative colitis or Crohn’s disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Mirikizumab
    Denmark Germany Italy Poland Spain

  • A study of acalabrutinib and venetoclax for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who have relapsed after initial treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia recurrent
    Investigated Drugs:
    • Acalabrutinib
    • Venetoclax
    Austria Czechia Ireland Italy Poland Spain

  • A study to evaluate the effectiveness of lenalidomide, pyrimethamine, and topiramate in reducing the HIV reservoir in people living with HIV.

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Pyrimethamine
    • Topiramate
    • Lenalidomide
    The Netherlands
Previous Page
1 … 23 24 25 26 27 … 1,645
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!